Insider Selling Continues to Shake Up Recursion’s Share Price
The latest filing from Chief Financial Officer Taylor Ben R on September 15, 2026 shows a modest sale of 5,396 shares of Class A common stock at $3.41 each, reducing his holding to 1,071,462 shares. While the transaction size is small relative to his overall stake, it is part of a longer trend of frequent sales that has been unfolding since mid‑2025. The CFO has sold roughly 95 % of his shares in the past 12 months, with the majority of those sales occurring in June, August and September, all at prices hovering around the $3.10‑$3.40 range. This pattern coincides with a sharp decline in Recursion’s share price from a 52‑week high of $7.18 in October 2025 to a 2.77 low in May 2026, and a year‑to‑date loss of 35 %.
What This Means for Investors
A series of insider sales can be interpreted in several ways. On one hand, the CFO’s consistent divestitures could signal a lack of confidence in the company’s near‑term prospects, especially given the negative price‑earnings ratio and the company’s recent quarterly earnings miss. On the other hand, the sales have been executed at prices only slightly below the prevailing market rate, suggesting that the CFO may be taking advantage of short‑term liquidity needs or tax considerations (note the footnote on tax withholding for RSU settlements). For investors, the key takeaway is that insider activity remains a bearish barometer, yet the volume of shares sold relative to the company’s market cap (~$1.7 billion) is still modest. A cautious stance is warranted, particularly as the stock has been under pressure since the May low and is still far below its 52‑week high.
Taylor Ben R: A Profile Built on Consistent Selling
Taylor Ben R has been a key member of Recursion’s executive team since 2022, and his insider trading history reflects a clear preference for gradual liquidation. Over the past 18 months he has sold more than 250,000 shares, averaging $3.20 per share, with a notable spike in August (25,018 shares at $3.16) and a smaller, more frequent pattern in June (5,396 shares at $3.15). He has also made a handful of purchases (e.g., 446,279 shares in February 2026 at $0.00, indicating a block purchase at the exercise price of a stock option). His trades are tightly clustered around earnings announcements and product‑pipeline updates, suggesting a strategy that aligns with corporate milestones rather than opportunistic market timing.
Broader Insider Activity Signals Caution
Recursion’s other top executives have followed a similar selling trajectory. CEO Khan Najat sold 80,498 shares in August and 22,408 shares in September, while Chief Scientific Officer David Hallett sold 26,657 shares in August. The collective insider sales create a bearish narrative that may deter speculative investors, yet the overall share base remains largely in the hands of institutional and private investors. For long‑term holders, the current insider trend may simply reflect a normal rebalancing exercise rather than a fundamental shift in company strategy.
Bottom Line
The CFO’s recent sale is part of an ongoing pattern of insider liquidity that signals caution but not necessarily a dire outlook. Investors should monitor Recursion’s quarterly earnings, product development milestones, and any changes in executive sentiment before making a decisive investment move. In a market where the stock is trading at $3.24—down 0.78 % from the previous week—any insider buying could be a positive sign, while continued selling may reinforce a bearish bias until the company demonstrates a clear upside catalyst.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-09-15 | Taylor Ben R (Chief Financial Officer) | Sell | 5,396.00 | 3.41 | Class A Common Stock |
